GlassScriptPhysician profile
Marcia Haught
NPI 1568783702
$2,124.33
in general payments reported to CMS, 2019-2025
18 companies · $126 in 2025
The $126 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $570 · 2020: $345 · 2021: $340 · 2022: $239 · 2023: $426 · 2024: $79.07 · 2025: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $631.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $630.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $988.63 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $250.91 | 2019-2023 | Mounjaro |
| Pfizer INC. | $176.43 | 2019-2024 | |
| Glaxosmithkline, LLC. | $154.05 | 2019-2023 | Shingrix, Arexvy, Trelegy Ellipta |
| Abbvie INC. | $107.97 | 2021-2025 | |
| Amgen INC. | $96.70 | 2019-2023 | Evenity, Prolia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $69.87 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $66.17 | 2022-2025 | Farxiga, Brilinta |
| Janssen Pharmaceuticals, INC | $38.45 | 2019-2023 | Xarelto |
| Teva Pharmaceuticals USA, INC. | $38.36 | 2019-2020 | |
| Nevro Corp. | $25.15 | 2021 | |
| Corcept Therapeutics | $24.30 | 2022 | |
| Sanofi-Aventis U.S. LLC | $17.93 | 2023 | |
| Sunovion Pharmaceuticals INC. | $16.35 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $16.06 | 2023 | Eliquis |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $13.21 | 2019 | |
| Allergan, INC. | $12.38 | 2019 | |
| Merck Sharp & Dohme LLC | $11.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcia Haught listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.